Cargando…
Development of a tropoelastin-binding MR contrast agent for in vivo imaging of impaired elastogenesis in atherosclerosis
Autores principales: | Phinikaridou, Alkystis, Lacerda, Sara, Andia, Marcelo E, Botnar, Rene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4328333/ http://dx.doi.org/10.1186/1532-429X-17-S1-O102 |
Ejemplares similares
-
Imaging of Dysfunctional
Elastogenesis in Atherosclerosis
Using an Improved Gadolinium-Based Tetrameric MRI Probe Targeted to
Tropoelastin
por: Capuana, Federico, et al.
Publicado: (2021) -
Tropoelastin: an in vivo imaging marker of dysfunctional matrix turnover during abdominal aortic dilation
por: Lavin, Begoña, et al.
Publicado: (2019) -
Noninvasive MRI Monitoring of the Effect of Interventions on Endothelial Permeability in Murine Atherosclerosis Using an Albumin‐Binding Contrast Agent
por: Phinikaridou, Alkystis, et al.
Publicado: (2013) -
Molecular MRI of Atherosclerosis
por: Phinikaridou, Alkystis, et al.
Publicado: (2013) -
Multi-sequence non-contrast MRI characterization of deep vein thrombosis in man
por: Phinikaridou, Alkystis, et al.
Publicado: (2015)